1042 related articles for article (PubMed ID: 9274623)
1. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions.
Böni R; Burg G; Doguoglu A; Ilg EC; Schäfer BW; Müller B; Heizmann CW
Br J Dermatol; 1997 Jul; 137(1):39-43. PubMed ID: 9274623
[TBL] [Abstract][Full Text] [Related]
2. Aberrantly differentiated cells in benign pilomatrixoma reflect the normal hair follicle: immunohistochemical analysis of Ca-binding S100A2, S100A3 and S100A6 proteins.
Kizawa K; Toyoda M; Ito M; Morohashi M
Br J Dermatol; 2005 Feb; 152(2):314-20. PubMed ID: 15727645
[TBL] [Abstract][Full Text] [Related]
3. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma].
Pluot M; Joundi A; Grosshans E
Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764
[TBL] [Abstract][Full Text] [Related]
4. S100A6 protein expression is different in Spitz nevi and melanomas.
Ribé A; McNutt NS
Mod Pathol; 2003 May; 16(5):505-11. PubMed ID: 12748257
[TBL] [Abstract][Full Text] [Related]
5. Ca(2+)-binding proteins S100A6 and S100B in primary cutaneous melanoma.
Böni R; Heizmann CW; Doguoglu A; Ilg EC; Schäfer BW; Dummer R; Burg G
J Cutan Pathol; 1997 Feb; 24(2):76-80. PubMed ID: 9162739
[TBL] [Abstract][Full Text] [Related]
6. Immunophenotypic markers to differentiate between benign and malignant melanocytic lesions.
Keijser S; Missotten GS; Bonfrer JM; de Wolff-Rouendaal D; Jager MJ; de Keizer RJ
Br J Ophthalmol; 2006 Feb; 90(2):213-7. PubMed ID: 16424536
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors.
Nonaka D; Chiriboga L; Rubin BP
J Cutan Pathol; 2008 Nov; 35(11):1014-9. PubMed ID: 18547346
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of growth hormone receptor immunoreactivity in human melanoma.
Lincoln DT; Sinowatz F; Kölle S; Takahashi H; Parsons P; Waters M
Anticancer Res; 1999; 19(3A):1919-31. PubMed ID: 10470136
[TBL] [Abstract][Full Text] [Related]
9. Expression of S100 protein family members in normal skin and sweat gland tumors.
Zhu L; Okano S; Takahara M; Chiba T; Tu Y; Oda Y; Furue M
J Dermatol Sci; 2013 Jun; 70(3):211-9. PubMed ID: 23623205
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of the S100A1, S100B, CD44 and Bcl-2 antigens and the rate of cell proliferation assessed by Ki-67 antibody in benign and malignant melanocytic tumours.
Sviatoha V; Tani E; Kleina R; Sperga M; Skoog L
Melanoma Res; 2010 Apr; 20(2):118-25. PubMed ID: 20042890
[TBL] [Abstract][Full Text] [Related]
11. Localization of S100A2, S100A4, S100A6, S100A7, and S100P in the human hair follicle.
Mitoma C; Kohda F; Mizote Y; Miake A; Ijichi A; Kawahara S; Kohno M; Sonoyama H; Mitamura Y; Kaku Y; Inoue H; Sasaki Y; Ohno F; Okabe N; Take N; Mizote M; Masuda A; Furue M
Fukuoka Igaku Zasshi; 2014 Jul; 105(7):148-56. PubMed ID: 25507257
[TBL] [Abstract][Full Text] [Related]
12. Localization of S100A2, S100A4, S100A6, S100A7, and S100P in the human hair follicle.
Mitoma C; Kohda F; Mizote Y; Miake A; Ijichi A; Kawahara S; Kohno M; Sonoyama H; Mitamura Y; Kaku Y; Inoue H; Sasaki Y; Ohno F; Okabe N; Take N; Mizote M; Masuda A; Furue M
Fukuoka Igaku Zasshi; 2014 Jul; 105(7):148-56. PubMed ID: 25417529
[TBL] [Abstract][Full Text] [Related]
13. Localization of Ca(2+)-binding S100 proteins in epithelial tumours of the skin.
Shrestha P; Muramatsu Y; Kudeken W; Mori M; Takai Y; Ilg EC; Schafer BW; Heizmann CW
Virchows Arch; 1998 Jan; 432(1):53-9. PubMed ID: 9463588
[TBL] [Abstract][Full Text] [Related]
14. Expression patterns of S100 proteins in melanocytes and melanocytic lesions.
Petersson S; Shubbar E; Enerbäck L; Enerbäck C
Melanoma Res; 2009 Aug; 19(4):215-25. PubMed ID: 19521263
[TBL] [Abstract][Full Text] [Related]
15. Comparative distribution of S-100 protein and antigen HMB-45 in various types of melanomas and naevi.
Mirecka J; Korabiowska M; Schauer A
Pol J Pathol; 1995; 46(3):167-72. PubMed ID: 7496736
[TBL] [Abstract][Full Text] [Related]
16. [Reactivity of five different antibodies with benign and malignant melanocytic lesions].
Plótár V; Szentirmay Z; Orosz Z
Magy Onkol; 2008 Dec; 52(4):363-73. PubMed ID: 19068464
[TBL] [Abstract][Full Text] [Related]
17. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
[TBL] [Abstract][Full Text] [Related]
18. S100 protein, neurone specific enolase, and nuclear DNA content in Spitz naevus.
Rode J; Williams RA; Jarvis LR; Dhillon AP; Jamal O
J Pathol; 1990 May; 161(1):41-5. PubMed ID: 2370597
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrilysin (matrix metalloproteinase-7) in primary cutaneous and metastatic melanoma.
Kawasaki K; Kawakami T; Watabe H; Itoh F; Mizoguchi M; Soma Y
Br J Dermatol; 2007 Apr; 156(4):613-9. PubMed ID: 17493064
[TBL] [Abstract][Full Text] [Related]
20. Micro-anatomy related antigen expression in melanocytic lesions.
Meije CB; Mooi WJ; Le Poole IC; Van Muijen GN; Das PK
J Pathol; 2000 Apr; 190(5):572-8. PubMed ID: 10727983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
